Regeneron Stock Probability of Future Stock Price Finishing Over 735.13

REGN
 Stock
  

USD 735.13  46.26  6.72%   

Regeneron Pharmaceuticals' future price is the expected price of Regeneron Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Regeneron Pharmaceuticals performance during a given time horizon utilizing its historical volatility.
  
Regeneron Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Regeneron Pharmaceuticals. Implied volatility approximates the future value of Regeneron Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Regeneron Pharmaceuticals over a specific time period. For example, 2022-10-07 CALL at $735.0 is a CALL option contract on Regeneron Pharmaceuticals' common stock with a strick price of 735.0 expiring on 2022-10-07. The contract was last traded on 2022-09-30 at 11:48:20 for $4.5 and, as of today, has 4 days remaining before the expiration. The option is currently trading at a bid price of $2.65, and an ask price of $4.6. The implied volatility as of the 3rd of October is 53.1971. View All Regeneron options

Closest to current price Regeneron long CALL Option Payoff at Expiration

Additionally, take a look at Regeneron Pharmaceuticals Backtesting, Regeneron Pharmaceuticals Valuation, Regeneron Pharmaceuticals Correlation, Regeneron Pharmaceuticals Hype Analysis, Regeneron Pharmaceuticals Volatility, Regeneron Pharmaceuticals History as well as Regeneron Pharmaceuticals Performance. Please specify Regeneron Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Regeneron Pharmaceuticals odds to be computed.

Regeneron Pharmaceuticals Target Price Odds to finish over 735.13

The tendency of Regeneron Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 735.13 90 days 735.13 
about 1.06
Based on a normal probability distribution, the odds of Regeneron Pharmaceuticals to move above the current price in 90 days from now is about 1.06 (This Regeneron Pharmaceuticals probability density function shows the probability of Regeneron Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Regeneron Pharmaceuticals has a beta of 1.0 indicating Regeneron Pharmaceuticals market returns are very sensitive to returns on the market. As the market goes up or down, Regeneron Pharmaceuticals is expected to follow. Additionally The company has an alpha of 0.3643, implying that it can generate a 0.36 percent excess return over DOW after adjusting for the inherited market risk (beta).
   Regeneron Pharmaceuticals Price Density   
       Price  

Predictive Modules for Regeneron Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regeneron Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Regeneron Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Regeneron Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
706.61711.11794.08
Details
Intrinsic
Valuation
LowReal ValueHigh
649.70772.25776.75
Details
15 Analysts
Consensus
LowTarget PriceHigh
575.00706.85844.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regeneron Pharmaceuticals. Your research has to be compared to or analyzed against Regeneron Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Regeneron Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Regeneron Pharmaceuticals is not an exception. The market had few large corrections towards the Regeneron Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Regeneron Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Regeneron Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.36
β
Beta against DOW1.00
σ
Overall volatility
46.33
Ir
Information ratio 0.13

Regeneron Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regeneron Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regeneron Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Regeneron Pharmaceuticals has very high historical volatility over the last 90 days
Regeneron Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 88.0% of the company shares are owned by institutional investors
Latest headline from www.benzinga.com: 100 Invested In This Stock 10 Years Ago Would Be Worth 500 Today - Regeneron Pharmaceuticals NASDAQRE - Benzinga

Regeneron Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Regeneron Stock often depends not only on the future outlook of the current and potential Regeneron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regeneron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.60%
Short Percent Of Float2.76%
Float Shares103.13M
Average Daily Volume Last 10 Day790.3k
Shares Short Prior Month2.58M
Average Daily Volume In Three Month678.36k
Date Short Interest15th of July 2022

Regeneron Pharmaceuticals Technical Analysis

Regeneron Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Regeneron Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. In general, you should focus on analyzing Regeneron Stock price patterns and their correlations with different microeconomic environments and drivers.

Regeneron Pharmaceuticals Predictive Forecast Models

Regeneron Pharmaceuticals time-series forecasting models is one of many Regeneron Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Regeneron Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Regeneron Pharmaceuticals

Checking the ongoing alerts about Regeneron Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Regeneron Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Regeneron Pharmaceuticals has very high historical volatility over the last 90 days
Regeneron Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 88.0% of the company shares are owned by institutional investors
Latest headline from www.benzinga.com: 100 Invested In This Stock 10 Years Ago Would Be Worth 500 Today - Regeneron Pharmaceuticals NASDAQRE - Benzinga
Additionally, take a look at Regeneron Pharmaceuticals Backtesting, Regeneron Pharmaceuticals Valuation, Regeneron Pharmaceuticals Correlation, Regeneron Pharmaceuticals Hype Analysis, Regeneron Pharmaceuticals Volatility, Regeneron Pharmaceuticals History as well as Regeneron Pharmaceuticals Performance. Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Regeneron Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.